Oral forms of a phosphonic acid derivative
US8980868B2 · kind B2 · utility
1Cited by
3References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2010 |
| Grant date | Mar 17, 2015 |
| Priority date | — |
| Expiry date | Feb 25, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6506
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel solution complexes of zoledronic acid are described which give rise to improved properties of zoledronic acid. The invention includes aqueous solution and molecular complexes of zoledronic acid with and optical isomers of asparagine, histidine, arginine and proline as well as pharmaceutical complexes containing them and methods of treatment using them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.